Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
9.26
-0.24 (-2.53%)
At close: Apr 28, 2026, 4:00 PM EDT
9.31
+0.05 (0.54%)
Pre-market: Apr 29, 2026, 5:48 AM EDT
Climb Bio Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 442 | 191 | 121 | 74 | 98 | 278 | |
| Market Cap Growth | 465.13% | 57.83% | 62.54% | -23.65% | -64.90% | - | |
| Enterprise Value | 282 | 16 | -97 | -33 | -32 | 108 | |
| Last Close Price | 9.26 | 4.00 | 1.80 | 2.70 | 3.67 | 10.46 | |
| PB Ratio | 2.76 | 1.19 | 0.57 | 0.69 | 0.76 | 1.66 | |
| P/TBV Ratio | 2.76 | 1.19 | 0.57 | 0.69 | 0.76 | 1.66 | |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | |
| Net Debt / Equity Ratio | -1.00 | -1.00 | -1.00 | -0.99 | -0.96 | -0.96 | |
| Net Debt / EBITDA Ratio | 2.36 | 2.36 | - | - | - | - | |
| Net Debt / FCF Ratio | 2.94 | 2.94 | 13.62 | 5.17 | 3.29 | 4.47 | |
| Quick Ratio | 14.47 | 14.47 | 30.61 | 38.57 | 21.35 | 23.79 | |
| Current Ratio | 15.16 | 15.16 | 31.41 | 38.92 | 22.04 | 24.58 | |
| Return on Equity (ROE) | -32.15% | -32.15% | -46.26% | -29.72% | -30.58% | -50.16% | |
| Return on Assets (ROA) | -22.04% | -22.04% | -10.30% | -10.93% | -18.30% | -22.54% | |
| Return on Capital Employed (ROCE) | -42.20% | -42.20% | -12.70% | -19.90% | -35.00% | -21.30% | |
| Earnings Yield | -13.53% | -31.34% | -61.07% | -47.17% | -46.40% | -17.09% | |
| FCF Yield | -12.33% | -28.56% | -12.86% | -27.67% | -38.33% | -12.99% | |
| Buyback Yield / Dilution | -40.80% | -40.80% | -78.47% | -2.57% | -114.60% | -460.40% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.